Biocrates

Innsbruck, Austria Founded: 2002 • Age: 24 yrs Acquired By Bruker
Targeted metabolic phenotyping kits are developed for research and diagnostics.
Request Access

About Biocrates

Biocrates is a company based in Innsbruck (Austria) founded in 2002 was acquired by Bruker in June 2025.. Biocrates has raised $7.87 million across 9 funding rounds from investors including BASF, Bruker and European Union. Biocrates has completed 1 acquisition, including Metanomics Health. Biocrates offers products and services including MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ. Biocrates operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.

  • Headquarter Innsbruck, Austria
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Biocrates Life Sciences Ag
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.87 M (USD)

    in 9 rounds

  • Latest Funding Round
  • Investors
    BASF

    & 5 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Bruker

    (Jun 03, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biocrates

Biocrates offers a comprehensive portfolio of products and services, including MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Kit for comprehensive metabolic profiling of lipids and small molecules.

Kit to study disease mechanisms and microbiome interactions.

High-resolution tool for targeted metabolomics data analysis.

Software for sample registration and metabolite quantification.

People of Biocrates
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Gordian Adam
Senior Scientist | Team Lead Insights & Innovation
People
Ulf Sommer
Principal Scientist Product Development
People
Alice Limonciel
Chief Scientific Officer
People
Gregor Ömer
Scientist - Team Lead Production

Unlock access to complete

Funding Insights of Biocrates

Biocrates has successfully raised a total of $7.87M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 9
  • Last Round
  • First Round

    (23 Jun 2006)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2019 Amount Series B - Biocrates Valuation MIG Fonds , Global Asset Fund
Feb, 2018 Amount Grant - Biocrates Valuation

investors

Jan, 2018 Amount Series B - Biocrates Valuation BASF , MIG Fonds
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biocrates

Biocrates has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include BASF, Bruker and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments in technology companies are managed by MIG Fonds.
Founded Year Domain Location
-
Founded Year Domain Location
Investments are focused on Austrian tech and life sciences startups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biocrates

Biocrates has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Metanomics Health. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Metabolomics products and services are offered for health applications.
2003
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Biocrates

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biocrates Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biocrates

Biocrates operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
RNA-editing technologies are provided for precision medicine applications.
domain founded_year HQ Location
Dental implants and regenerative dentistry products are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biocrates

Frequently Asked Questions about Biocrates

When was Biocrates founded?

Biocrates was founded in 2002 and raised its 1st funding round 4 years after it was founded.

Where is Biocrates located?

Biocrates is headquartered in Innsbruck, Austria. It is registered at Innsbruck, Tyrol, Austria.

Is Biocrates a funded company?

Biocrates is a funded company, having raised a total of $7.87M across 9 funding rounds to date.

What does Biocrates do?

Biocrates was founded in 2002 in Innsbruck, Austria, within the life sciences sector. Kits for targeted metabolic phenotyping are offered in two lines: research tools that quantify 188 metabolites across classes like bile salts and steroids, and diagnostic tests for analyzing 16 steroid hormones. Proprietary software is utilized to manage workflows, standardize data processing, and support project harmonization in metabolite analysis.

Who are the top competitors of Biocrates?

Biocrates's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

What products or services does Biocrates offer?

Biocrates offers MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ.

How many acquisitions has Biocrates made?

Biocrates has made 1 acquisition, including Metanomics Health.

Who are Biocrates's investors?

Biocrates has 6 investors. Key investors include BASF, Bruker, European Union, MIG Fonds, and Global Asset Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available